SLAS2014

18 January 2014 - 22 January 2014

SLAS2014 will feature an outstanding scientific program of 130 podium sessions, hundreds of posters, 17 short courses, exhibitor tutorials, and satellite symposia. The seven educational tracks include: Assay Development and Screening, Automation and High Throughput Technologies, Drug Target Biology, Micro/Nano Technologies, Bioanalytical Techniques, Informatics and Diagnostics & Biomarkers.

San Diego Convention Center, San Diego, CA, USA

SLAS2014

18 January 2014 - 22 January 2014

SLAS2014 will feature an outstanding scientific program of 130 podium sessions, hundreds of posters, 17 short courses, exhibitor tutorials, and satellite symposia. The seven educational tracks include: Assay Development and Screening, Automation and High Throughput Technologies, Drug Target Biology, Micro/Nano Technologies, Bioanalytical Techniques, Informatics and Diagnostics & Biomarkers.

San Diego Convention Center, San Diego, CA, USA

SLAS2014

18 January 2014 - 22 January 2014

SLAS2014 will feature an outstanding scientific program of 130 podium sessions, hundreds of posters, 17 short courses, exhibitor tutorials, and satellite symposia. The seven educational tracks include: Assay Development and Screening, Automation and High Throughput Technologies, Drug Target Biology, Micro/Nano Technologies, Bioanalytical Techniques, Informatics and Diagnostics & Biomarkers.

San Diego Convention Center, San Diego, CA, USA

SMi presents the 3^rd annual conference on...

Pharmaceutical Microbiology

Marriott Regents Park Hotel, London UK

20-21 Jan 2014

SMi’s reputable Pharamceutical Microbiology conference returns for its 3^rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.

KEY BENEFITS OF ATTENDING:

·         Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

·         Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

·         Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

·         Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

·         Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.

KEY SPEAKERS:

·         Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

·         Mary-Anne Weatherhead, Qualified Person, Pfizer

·         Andrew Bartko, Senior Scientist, Battelle

·         William Wade, Professor of Oral Microbiology, Barts and The London

·         Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

·         Amy McDaniel, Associate Director, Production Operations, Pfizer

·         Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

·         Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

·         Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

·         Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

·         Stephen Rawling, Microbiology Team Leader, GSK

·         John Duguid, Principal Process Analytical Scientist, Genzyme

·         Kim Bowers, Senior Supervisor, Pfizer

·         Hilary Chan, Quality Scientist IV, Pfizer

·         Erika Pfeiler, Microbiologist, FDA

·         Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Alternatively contact John Collins on +44(0)20 7827 6734 or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it  

SLAS2014

18 January 2014 - 22 January 2014

SLAS2014 will feature an outstanding scientific program of 130 podium sessions, hundreds of posters, 17 short courses, exhibitor tutorials, and satellite symposia. The seven educational tracks include: Assay Development and Screening, Automation and High Throughput Technologies, Drug Target Biology, Micro/Nano Technologies, Bioanalytical Techniques, Informatics and Diagnostics & Biomarkers.

San Diego Convention Center, San Diego, CA, USA

SMi presents the 3^rd annual conference on...

Pharmaceutical Microbiology

Marriott Regents Park Hotel, London UK

20-21 Jan 2014

SMi’s reputable Pharamceutical Microbiology conference returns for its 3^rd installment on 20th and 21st January, 2014, London UK.

Pharmaceutical Microbiology 2014 will draw upon the experiences and knowledge from experts and specialists around the globe to provide first-class presentations and stimulating discussions.

The conference will aim to focus on the regulatory aspect, with topics addressing preparations for auditing, what to expect during the inspection process, and how to rectify poor situations. There will also be considerable spotlight on novel rapid methods, case studies from the USA, their implementation, and the current regulatory view on methods. Among these hot topics the event will also examine sterility assessment, risk management, and contamination control.

KEY BENEFITS OF ATTENDING:

·         Regulatory body representation and update – what to expect from inspection, how to prepare your lab, and how to rectify situations when things go wrong.

·         Discover cutting edge rapid methods, how to implement the technology, and the regulatory stance

·         Hear specialist advice on contamination control and risk management to minimise costs and maximise efficiency

·         Learn about hot topics which include objectionable organisms, viral contaminations, update on the pharmacopeias, and quality by design.

·         Discuss case studies and experiences with expert speakers and delegates from across the UK, USA, and Europe.

KEY SPEAKERS:

·         Phil Duncanson, Site Microbiologist & QC Lead, MedImmune

·         Mary-Anne Weatherhead, Qualified Person, Pfizer

·         Andrew Bartko, Senior Scientist, Battelle

·         William Wade, Professor of Oral Microbiology, Barts and The London

·         Brendan Gilmore, Senior Lecturer in Pharmaceutical Microbiology, Queen’s University Belfast

·         Amy McDaniel, Associate Director, Production Operations, Pfizer

·         Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

·         Pierre Raboisson, Head of Medicinal Chemistry, Johnson & Johnson

·         Olivier Chancel, Head of Pharmaceutical Support, Merial Sas (Sanofi)

·         Di Morris, Consultant, Pharmaceutical Solutions Ltd. (ex-MHRA)

·         Stephen Rawling, Microbiology Team Leader, GSK

·         John Duguid, Principal Process Analytical Scientist, Genzyme

·         Kim Bowers, Senior Supervisor, Pfizer

·         Hilary Chan, Quality Scientist IV, Pfizer

·         Erika Pfeiler, Microbiologist, FDA

·         Steven Donald, Microbiologist, FDA

The previous 2 events in the Microbiology series received positive feedback from the industry including Thermo Fischer Scientific – “The delegate quality was good” , Pfizer – “Topics were interesting and relevant” and Groninger & co gmbh- Very diverse multi facetted event

Alternatively contact John Collins on +44(0)20 7827 6734 or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it  

SLAS2014

18 January 2014 - 22 January 2014

SLAS2014 will feature an outstanding scientific program of 130 podium sessions, hundreds of posters, 17 short courses, exhibitor tutorials, and satellite symposia. The seven educational tracks include: Assay Development and Screening, Automation and High Throughput Technologies, Drug Target Biology, Micro/Nano Technologies, Bioanalytical Techniques, Informatics and Diagnostics & Biomarkers.

San Diego Convention Center, San Diego, CA, USA

Social Media in the Pharmaceutical Industry

22 January 2014 - 23 January 2014

As social media becomes increasingly integrated into society, so does the ability to network with one another. Corporate marketing has become a discussion, with two way channels of communication. Companies are accurately targeting specific products at the most relevant markets, consumers are able to share experiences and discuss ideas, and the industry-consumer relationship is extended well beyond the point of sale. With health at the top of any patient’s agenda the opportunity for pharma to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Marriott Regents Park Hotel, London, UK

Social Media in the Pharmaceutical Industry

22 January 2014 - 23 January 2014

As social media becomes increasingly integrated into society, so does the ability to network with one another. Corporate marketing has become a discussion, with two way channels of communication. Companies are accurately targeting specific products at the most relevant markets, consumers are able to share experiences and discuss ideas, and the industry-consumer relationship is extended well beyond the point of sale. With health at the top of any patient’s agenda the opportunity for pharma to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Marriott Regents Park Hotel, London, UK

4th Annual Pharmacovigilance and Risk Management Strategies Forum

23 January 2014 - 24 January 2014

Amsterdam, Netherlands

4th Annual Pharmacovigilance and Risk Management Strategies Forum

23 January 2014 - 24 January 2014

Amsterdam, Netherlands

SMi are extremely proud to present their 6th annual Pre-filled Syringes meeting taking place on the 27^th-28^th January 2014. With one of the most established European market leaders on this subject and the huge successes of their previous meetings, SMi will provide another great forum for new advances in this field.

Pre-filled syringes are continuing to make huge roadways in the applications of new therapeutic drugs, there are a number of challenges that must be overcome. Formulation and drug interactions with container material, filling equipment and drug stability are consistent problems. Allow PFS 14' to show you how these challenges are overcome and provide a range of answers through case studies exactly how your PFS can operate at its full capability.

Key reasons to attend:

• Learn about the latest regulatory updates from MHRA and FDA bodies
• Hear exclusive news on autoinjector technologies
• Hear about manufacturing of container integrity and reduction in leachables
• Expand your professional network, meet leading specialists within the industry
• Get a chance to introduce your company and its services to potential partners

Keynote speakers include:

• Advait Badkar, Bioprocess R&D, Pfizer
• Joel Richards, Director, Ipsen
• Brij Patel, CEO, RegExcel (Former Biological Assessor, MHRA)
• Khalil Razvi, Consultant, Southend NHS Trust
• Adam Woolley, CEO, ForthTox
• Dale Charlton, Business Development Director, Optima Pharma

SMi are extremely proud to present their 6th annual Pre-filled Syringes meeting taking place on the 27^th-28^th January 2014. With one of the most established European market leaders on this subject and the huge successes of their previous meetings, SMi will provide another great forum for new advances in this field.

Pre-filled syringes are continuing to make huge roadways in the applications of new therapeutic drugs, there are a number of challenges that must be overcome. Formulation and drug interactions with container material, filling equipment and drug stability are consistent problems. Allow PFS 14' to show you how these challenges are overcome and provide a range of answers through case studies exactly how your PFS can operate at its full capability.

Key reasons to attend:

• Learn about the latest regulatory updates from MHRA and FDA bodies
• Hear exclusive news on autoinjector technologies
• Hear about manufacturing of container integrity and reduction in leachables
• Expand your professional network, meet leading specialists within the industry
• Get a chance to introduce your company and its services to potential partners

Keynote speakers include:

• Advait Badkar, Bioprocess R&D, Pfizer
• Joel Richards, Director, Ipsen
• Brij Patel, CEO, RegExcel (Former Biological Assessor, MHRA)
• Khalil Razvi, Consultant, Southend NHS Trust
• Adam Woolley, CEO, ForthTox
• Dale Charlton, Business Development Director, Optima Pharma

Oncology Biologics: Paradigm Shift in Cancer Treatment

28 January 2014 - 29 January 2014

This innovative event will focus on current innovations in oncology biologics as well as future drug development and novel treatment options. This conference will discuss the advancement in a board variety of oncology biologics including: •Immunotherapy and cancer vaccines •Antibody-drug conjugates (mix of antibody + toxin – targeted delivery) to target tumors •Immunoconjugates •Anti-angiogenesis biologics •Stem cell targeting biologics •Novel biologics beyond antibodies •Bispecific antibodies •Oncology biologics enabling diagnostics technologies •Personalized cancer treatment

Hyatt Boston Harbour, Boston, MA, USA

Oncology Biologics: Paradigm Shift in Cancer Treatment

28 January 2014 - 29 January 2014

This innovative event will focus on current innovations in oncology biologics as well as future drug development and novel treatment options. This conference will discuss the advancement in a board variety of oncology biologics including: •Immunotherapy and cancer vaccines •Antibody-drug conjugates (mix of antibody + toxin – targeted delivery) to target tumors •Immunoconjugates •Anti-angiogenesis biologics •Stem cell targeting biologics •Novel biologics beyond antibodies •Bispecific antibodies •Oncology biologics enabling diagnostics technologies •Personalized cancer treatment

Hyatt Boston Harbour, Boston, MA, USA

Novel Immunoassays Workshop - Platform & Methods for Consistent Results

29 January 2014

This workshop is intended for researchers and scientists interested in learning how to develop a reliable solid phase immunoassay (including PK and ADA assays) to support biological drug development. There are many assay related issues will be discussed and a new type of immunoassay platform will be introduced.

Wyndham San Diego Bayside, San Diego, CA, USA

Cytokines & Inflammation Conference

30 January 2014 - 31 January 2014

Over the years, GTC’s Cytokines & Inflammation Conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Our 12th annual meeting will take place January 29-31, 2014 in San Diego, CA, so mark your calendars and save the date! We will have presentations that cover a wide breadth of the latest hot topics, such as the metabolism of immune cells, innate lymphoid cells, gamma delta T cells, IL-33, and many more. The meeting is one of four concurrent conferences in the Novel Immunotherapeutics Summit, which features Nobel Laureate Jules A. Hoffmann as one of its keynote speakers.

Wyndham San Diego Bayside, San Diego, CA, USA

Novel Immunotherapeutics Summit

29 January 2014 - 31 January 2014

The Summit includes four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field: 12th Cytokines & Inflammation Researchers will join to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signalling pathways. Hot topics such as innate lymphoid cells and homeostasis on mucosal tissues will also be covered. 6th Immunotherapeutics & Immunomonitoring Leading experts will present about novel findings and developments in the constantly changing area of immunological assays and procedures. This meeting will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. 2nd Immunogenicity and Immunotoxicity Delegates will learn will about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins, and speakers will discuss the progress of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Inaugural Innate Immunity Come to learn more about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.

Wyndham San Diego Bayside, San Diego, CA, USA

SAN2014 Meeting

30 January 2014 - 02 February 2014

It is our great pleasure to welcome you to the conference website of the 2014 Meeting of the Society of Applied Neurosciences (SAN), jointly organized with the National Initiative Brain and Cognition (NIHC). The conference will be held from January 30th to February 2nd, 2014 in the Royal Dutch Jaarbeurs in Utrecht (The Netherlands). Confirmed keynote speakers include Niels Birbaumer, John Gruzelier, Pascal Fries, Katya Rubia and Thomas Schlaepfer. Further keynote and invited speakers will be announced later.

Royal Dutch Jaarbeurs, Utrecht, Netherlands

Cytokines & Inflammation Conference

30 January 2014 - 31 January 2014

Over the years, GTC’s Cytokines & Inflammation Conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Our 12th annual meeting will take place January 29-31, 2014 in San Diego, CA, so mark your calendars and save the date! We will have presentations that cover a wide breadth of the latest hot topics, such as the metabolism of immune cells, innate lymphoid cells, gamma delta T cells, IL-33, and many more. The meeting is one of four concurrent conferences in the Novel Immunotherapeutics Summit, which features Nobel Laureate Jules A. Hoffmann as one of its keynote speakers.

Wyndham San Diego Bayside, San Diego, CA, USA

SAN2014 Meeting

30 January 2014 - 02 February 2014

It is our great pleasure to welcome you to the conference website of the 2014 Meeting of the Society of Applied Neurosciences (SAN), jointly organized with the National Initiative Brain and Cognition (NIHC). The conference will be held from January 30th to February 2nd, 2014 in the Royal Dutch Jaarbeurs in Utrecht (The Netherlands). Confirmed keynote speakers include Niels Birbaumer, John Gruzelier, Pascal Fries, Katya Rubia and Thomas Schlaepfer. Further keynote and invited speakers will be announced later.

Royal Dutch Jaarbeurs, Utrecht, Netherlands